Beijing Bohui Innovation Biotechnology Group Co., Ltd. (SHE:300318)
China · Delayed Price · Currency is CNY 4.560
-0.060 (-1.30%)
Nov 6, 2026, 10:25 AM CST
SHE:300318 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 115.95 | 121.83 | 77.26 | 104.93 | 113.6 | 39.39 |
Cash & Short-Term Investments | 135.95 | 121.83 | 77.26 | 104.93 | 113.6 | 39.39 |
Cash Growth | 35.22% | 57.69% | -26.36% | -7.64% | 188.36% | -11.66% |
Accounts Receivable | 130.69 | 93.24 | 59.34 | 53.9 | 82.41 | 94.85 |
Other Receivables | 5.02 | 58.83 | 67.15 | 96.47 | 58.03 | 106.79 |
Receivables | 135.7 | 152.07 | 126.49 | 150.37 | 140.43 | 201.64 |
Inventory | 1,224 | 1,144 | 1,011 | 854.56 | 870.52 | 820.95 |
Prepaid Expenses | - | 0.09 | - | 0.08 | 0.03 | 0.01 |
Other Current Assets | 71.48 | 8.6 | 11.31 | 14.69 | 15.55 | 17.56 |
Total Current Assets | 1,567 | 1,427 | 1,226 | 1,125 | 1,140 | 1,080 |
Property, Plant & Equipment | 1,519 | 1,504 | 1,504 | 1,478 | 1,392 | 1,227 |
Long-Term Investments | 9.61 | 9.61 | 10.91 | 11.82 | 16.81 | 16.81 |
Goodwill | 786.27 | 786.27 | 786.27 | 786.27 | 786.27 | 802.19 |
Other Intangible Assets | 366.29 | 374.88 | 346.61 | 297.33 | 310.43 | 370.84 |
Long-Term Deferred Tax Assets | 4.97 | 5.83 | 3.6 | 3.68 | 2.72 | 2.38 |
Long-Term Deferred Charges | 72.91 | 80.55 | 124 | 90.34 | 73.3 | 56.25 |
Other Long-Term Assets | 111.74 | 116.33 | 123.64 | 134.23 | 186.32 | 135.03 |
Total Assets | 4,438 | 4,304 | 4,126 | 3,926 | 3,908 | 3,690 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 204.07 | 220.4 | 229.03 | 261.19 | 302.37 | 227.13 |
Accrued Expenses | 51 | 67.99 | 62.55 | 66 | 86.99 | 60.89 |
Short-Term Debt | 321.26 | 404.56 | 451.94 | 365.51 | 423.47 | 434.89 |
Current Portion of Long-Term Debt | 177.74 | 237.69 | 163.6 | 54.36 | 28.35 | 23.38 |
Current Portion of Leases | - | 11.05 | 7.56 | 6.76 | 3.56 | 2.53 |
Current Income Taxes Payable | 11.7 | 2.11 | 3.91 | 14.11 | 8.36 | 2.12 |
Current Unearned Revenue | 11.64 | 18.67 | 20.22 | 22.7 | 40.3 | 21.59 |
Other Current Liabilities | 999.05 | 568.29 | 275.13 | 274.23 | 229.44 | 1,762 |
Total Current Liabilities | 1,776 | 1,531 | 1,214 | 1,065 | 1,123 | 2,535 |
Long-Term Debt | 371.43 | 436.96 | 389.88 | 340.93 | 313.68 | 83.58 |
Long-Term Leases | 32.03 | 34.98 | 38.23 | 39.49 | 18.93 | 8.31 |
Long-Term Unearned Revenue | 21.61 | 21.33 | 28.56 | 31.62 | 17.51 | 17.75 |
Long-Term Deferred Tax Liabilities | 100.3 | 101.68 | 103.45 | 107.29 | 108.94 | 110.87 |
Other Long-Term Liabilities | 4.32 | 2.54 | 2.38 | 1.29 | 2.62 | 2.03 |
Total Liabilities | 2,306 | 2,128 | 1,776 | 1,585 | 1,585 | 2,757 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 816.9 | 816.9 | 816.9 | 816.9 | 816.9 | 816.9 |
Additional Paid-In Capital | 751.76 | 751.76 | 754.22 | 754.22 | 754.22 | 260.76 |
Retained Earnings | -311.45 | -286.82 | -194.89 | -204.14 | -179.21 | -100.68 |
Comprehensive Income & Other | 6.33 | 3.34 | 2.46 | 2.56 | 1.42 | -2.23 |
Total Common Equity | 1,264 | 1,285 | 1,379 | 1,370 | 1,393 | 974.75 |
Minority Interest | 867.83 | 890.81 | 970.44 | 971.01 | 930.17 | -42.01 |
Shareholders' Equity | 2,131 | 2,176 | 2,349 | 2,341 | 2,323 | 932.75 |
Total Liabilities & Equity | 4,438 | 4,304 | 4,126 | 3,926 | 3,908 | 3,690 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 902.45 | 1,125 | 1,051 | 807.04 | 787.99 | 552.68 |
Net Cash (Debt) | -766.5 | -1,003 | -973.95 | -702.11 | -674.39 | -513.29 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.94 | -1.23 | -1.19 | -0.86 | -0.83 | -0.63 |
Filing Date Shares Outstanding | 812.47 | 816.9 | 816.9 | 816.9 | 816.9 | 816.9 |
Total Common Shares Outstanding | 812.47 | 816.9 | 816.9 | 816.9 | 816.9 | 816.9 |
Working Capital | -209.67 | -103.73 | 12.39 | 59.78 | 17.29 | -1,455 |
Book Value Per Share | 1.56 | 1.57 | 1.69 | 1.68 | 1.71 | 1.19 |
Tangible Book Value | 110.99 | 124.03 | 245.81 | 285.94 | 296.63 | -198.28 |
Tangible Book Value Per Share | 0.14 | 0.15 | 0.30 | 0.35 | 0.36 | -0.24 |
Buildings | - | 564.49 | 558.46 | 538.42 | 527.25 | 523.98 |
Machinery | - | 649.63 | 633.52 | 639.97 | 649.6 | 629.9 |
Construction In Progress | - | 955.78 | 933.12 | 888.36 | 809.66 | 629.95 |